| Literature DB >> 33953459 |
Monish A Sheth1, Robert J Widmer2, Hari K Dandapantula2.
Abstract
Coronary artery vasospasm is a known cause of chest pain and requires a high level of clinical suspicion for diagnosis. It also remains in the differential diagnosis for patients presenting with type 2 myocardial infarction. There are few randomized controlled trials for guideline-based prevention and treatment for coronary artery vasospasm. In this article, we review updated concepts in coronary artery vasospasm. Specifically, our aim is to provide current evidence of pathophysiology, identify the risk factors, propose a diagnostic algorithm, review available evidence of evolving therapies, and identify patients who would benefit from automatic implantable cardioverter defibrillators.Entities:
Keywords: Automatic implantable cardioverter defibrillators; Prinzmetal angina; calcium channel blocker; coronary artery vasospasm; nitrates; nitroglycerin; type 2 myocardial infarction
Year: 2021 PMID: 33953459 PMCID: PMC8059918 DOI: 10.1080/08998280.2021.1898907
Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN: 0899-8280